Clinical TrialID 6630

TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)

NCT04400578

Cervical Intraepithelial Neoplasia Grade 1|Cervical Intraepithelial Neoplasia Grade 2

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
6630
Evidence Id
6630
Core Evidence Id
6630
Source Clinical Trial Id
6617
Herb2 Clinical Trial Id
HBCT006617
Nct Id
NCT04400578
Title
TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)
Status
Completed
Phase
Study Result
No
Study Condition
Cervical Intraepithelial Neoplasia Grade 1|Cervical Intraepithelial Neoplasia Grade 2
Study Type
Interventional
Study Design
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DEVICE: Trichloroacetic acid 85% (TCA)
Intervention Allocation
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Treatment
Gender
Female
Age
Adult
Enrollment
102
Outcome Measure
CIN remission rate after treatment with TCA 85%, measured by histologic remission within 6 months, 6 months
Sponsor Collaborator
Krankenhaus Barmherzige Schwestern Linz|Medical University of Vienna
Funded By
OTHER
Location
Department of gynaecology, Ordensklinikum Linz Ges.m.b.H, Barmherzige Schwestern, Linz, 4010, Austria
Other Id
EKS 48/19
Start Date
2020-02-07
Primary Completion Date
2022-01-18
Completion Date
2022-01-18
First Posted
2020-05-22
Results First Posted
Last Update Posted
2022-04-07
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04400578
Title Cn
Title En
TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)
Bilingual Status
semi_complete